Combination of advanced systemic therapy in atopic dermatitis: A multicentre observational study
- 22 June 2026
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- European Guideline (EuroGuiDerm) on atopic eczema: Living updateJournal of the European Academy of Dermatology and Venereology, 2025
- A Case Series of Refractory Pediatric Atopic Dermatitis Effectively Treated With Dupilumab in Combination With AbrocitinibPediatric Dermatology, 2024
- Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2024
- Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumabInternational Journal of Dermatology, 2023
- JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patientsJAAD Case Reports, 2023
- Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumabBritish Journal of Dermatology, 2022